MindWalk Holdings (HYFT) Depreciation and Depletion (2025 - 2026)
MindWalk Holdings (HYFT) posted quarterly Depreciation and Depletion of $67013.0 for Q1 2026, down 80.7% year-over-year from $347282.4 in Q1 2025, and down 81.9% quarter-over-quarter from $370338.0 in Q2 2025.
MindWalk Holdings (HYFT) Depreciation and Depletion (2025 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported Depreciation and Depletion for 2 consecutive years, with $67013.0 the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 67,012.98 |
| Jan 31, 2026 | 67,012.98 |
| Apr 30, 2025 | 370,338.02 |
| Apr 30, 2025 | 370,338.02 |
| Jan 31, 2025 | 347,282.44 |
| Jan 31, 2025 | 347,282.44 |